InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 43139

Saturday, 03/10/2018 12:28:09 PM

Saturday, March 10, 2018 12:28:09 PM

Post# of 48316
If you listen to the recent webcast from the LD Micro conference, Oncosec's CEO, Dan O'Connor, absolutely said the recent equity raise for 23 mil was to support (sponsor) a TNBC phase II trial in combination with checkpoint therapy....based on their pilot TNBC study at Stanford.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News